Principal Financial Group Inc Infinity Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.49 - $1.2 $12,986 - $31,804	-26,504 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$0.85 - $2.4 $1,263 - $3,568	1,487 Added 5.94%	26,504 $30,000
Q4 2021 Feb 09, 2022	SELL	$1.86 - $3.36 $19,881 - $35,915	-10,689 Reduced 29.94%	25,017 $56,000
Q3 2021 Nov 09, 2021	BUY	$1.52 - $3.82 $2,495 - $6,272	1,642 Added 4.82%	35,706 $122,000
Q2 2021 Aug 10, 2021	BUY	$2.66 - $3.47 $90,610 - $118,202	34,064 New	34,064 $101,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.